Translate
Liminatus Pharma, Inc.
About
0.25USD+0.06 +30.99%
Closed • Updated at 13:44 GMT+00:00Market Cap$11.04M
Volume322.15M
Beta5.70
RSI64.56
Liminatus Pharma, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Today
Liminatus Pharma Announces Nasdaq Delisting Notification
Mar 17 2026
Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody
Feb 17 2026
Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering
Oct 30 2025
Liminatus Pharma, Inc. (NASDAQ: LIMN) Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation
Jul 28 2025
Liminatus Pharma Inc. to Launch “American BNB Strategy” Subsidiary and Target Up To $500 Million Fund for BNB Investment as Part of Crypto Market Initiative
Recent Videos
Liminatus Pharma Going Concern: My Biggest Concern from the Report
May 21, 2026
LIMN Stock Analysis | Liminatus Pharma Inc Stock Latest Chart Update
May 21, 2026
Cómo invertir en Liminatus Pharma Inc (LIMN) paso a paso
Mar 28, 2026
How to Invest in Liminatus Pharma Inc (LIMN) Step by Step
Mar 19, 2026